
Reepag 0.5mg Tablet
Marketer
Johnlee Pharmaceuticals Pvt Ltd
Salt Composition
Repaglinide (0.5mg)
Overview Reepag 0.5mg Tablet
Glimepiride 0.5mg tablets help manage high blood sugar in adults with type 2 diabetes. This medication is typically used alongside other diabetes treatments to optimize blood sugar control and reduce the risk of serious complications, such as kidney disease and vision loss. It's usually prescribed when diet, exercise, and other medications haven't sufficiently lowered blood sugar. Optimal results are achieved by taking it before meals. Dosage is tailored to individual needs and blood sugar levels, always following your doctor's instructions. Consistent daily use, at the same time each day, is crucial for effectiveness and shouldn't be stopped without consulting your physician. Maintaining a healthy diet and exercise regimen, as recommended by your doctor, is vital for managing diabetes. Hypoglycemia (low blood sugar) is a common side effect; carrying glucose tablets can help manage this. Other possible side effects include stomach upset, sinusitis, joint pain, back pain, nausea, and diarrhea. Report any concerning or persistent side effects to your doctor. Before starting this medication, inform your doctor about any history of kidney disease, heart or pancreatic problems, or significant alcohol consumption. Pregnant or breastfeeding individuals should consult their doctor. Other medications you're taking may interact with this one, so ensure your doctor has a complete list of your current medications. Reduce alcohol intake while using this medication to minimize the hypoglycemia risk. Regular monitoring of kidney function and blood glucose levels will help assess treatment effectiveness.
Uses of Reepag 0.5mg Tablet
Managing type 2 diabetes
Major Benefits of Reepag 0.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Reepag 0.5mg Tablet on an empty stomach.
Common Side effects of Reepag 0.5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Nausea
- Diarrhea
- Back pain
- Joint pain
- Upper respiratory tract infection
- Headache
- Sinus inflammation
How to use Reepag 0.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.5mg Reepag tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Reepag 0.5mg Tablet works:
GlucoReg 0.5mg tablets are used to manage diabetes. They stimulate pancreatic insulin secretion, thus moderating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Reepag 0.5mg Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Reepag 0.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Reepag 0.5mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Reepag 0.5mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Reepag 0.5mg tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. Reepag 0.5mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Reepag 0.5mg Tablet :
Omit any missed Reepag 0.5mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Reepag 0.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Meglitinides |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Meglitinide Insulin Secretagogues |
